Adaptive Trial Design
– Takes about 4 minutes to read this topic – As long as their trials are well-designed and based on prior data, safeguard participants, and meet
EDC
One size does not fit all
Safety Notification
RTSM
Deliver powerful randomization methods
CODER
Fast and accurate clinical coding
Drug and Device Logistics
Mitigate risk and create closer connections
eTMF
Essential document collection
CTMS
Accelerate your trial and ensure data integrity
eCONSENT
Meet patients where they are
eCOA
Faster, cleaner and more reliable data
Patient Poll
Quick insights from patients
eCRF Setup
Capture better data, faster
eTMF Setup
Get up and running in no time
PV Management
Identify and handle your safety management needs
Data Management
Make more informed business decisions
Managed Service Model for MDR
Migration, Consulting and Customization for your MDR
Submission and Data Mapping
Move and consolidate data
eTechnology Strategy
Integrate and capitalize on critical technologies
Protocol Development
Turning your research question into a study
Observational Studies
Digital, cost effective and time efficient
Primary Market Research
Direct to patient, unique, and quality data
IRB and EC Management
End to end regulatory management
PV and GDPR Compliance
Safety, consent and data protection
Scientific Communications
Results dissemination
Digital Communications
Increase patient awareness
Data Linkage
Generate, combine and analyze data
– Takes about 4 minutes to read this topic – As long as their trials are well-designed and based on prior data, safeguard participants, and meet
– Takes 6 minutes to read this topic – In the early 20th century, the scientific community advocated for the use of “well-controlled” therapeutic drug trials. These relied
– Takes about 10 minutes to read this topic – Change is the only constant in clinical research. New data sources, new data types, and
– Takes about 10 minutes to read this topic – Clinical trials are crucial in advancing human health and the practice of medicine. From early
Launched in the early 1990s and completed in 2001, the Human Genome Project provided the basis for a wide range of studies of human biology
Alexander Fleming’s discovery of penicillin in the late 1920s revolutionized the treatment of infectious diseases. But the increasing prevalence of antibiotic resistance and the emergence of multidrug-resistant
EvidentIQ Group GmbH Rathausmarkt 5, 20095 Hamburg, Germany.
Copyright 2024 EvidentIQ
All Rights Reserved
Commercial Register: Hamburg HRB 147319
Sales Tax Identification Number: DE312852940
Managing Directors
Andreas Weber, Manuel Neukum, Axel Jansen, Lars Kloppsteck,
Helge Hofmeister
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Commercial Register: Hamburg, HRB 147319
Sales tax identification number: DE312852940
Follow us: